$0.35
10.59% day before yesterday
Nasdaq, Sep 06, 10:07 pm CET
ISIN
US09061H3075
Symbol
BMRA

Biomerica, Inc. Stock price

$0.35
+0.05 18.59% 1M
-0.82 70.34% 6M
-0.90 72.24% YTD
-0.91 72.46% 1Y
-4.37 92.65% 3Y
-2.72 88.70% 5Y
-0.50 59.18% 10Y
Nasdaq, Closing price Fri, Sep 06 2024
-0.04 10.59%
ISIN
US09061H3075
Symbol
BMRA
Sector

Key metrics

Market capitalization $5.84m
Enterprise Value $2.46m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.45
P/S ratio (TTM) P/S ratio 1.08
P/B ratio (TTM) P/B ratio 0.89
Revenue growth (TTM) Revenue growth 1.39%
Revenue (TTM) Revenue $5.41m
EBIT (operating result TTM) EBIT $-6.37m
Free Cash Flow (TTM) Free Cash Flow $-5.41m
Cash position $4.17m
EPS (TTM) EPS $-0.36
Short interest 0.34%
Show more

Is Biomerica, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Biomerica, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Biomerica, Inc.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Biomerica, Inc.:

Buy
100%

Financial data from Biomerica, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
May '24
+/-
%
5.41 5.41
1% 1%
100%
- Direct Costs 4.81 4.81
2% 2%
89%
0.61 0.61
36% 36%
11%
- Selling and Administrative Expenses 5.11 5.11
11% 11%
94%
- Research and Development Expense 1.49 1.49
6% 6%
28%
-5.99 -5.99
13% 13%
-111%
- Depreciation and Amortization 0.37 0.37
6% 6%
7%
EBIT (Operating Income) EBIT -6.37 -6.37
12% 12%
-118%
Net Profit -5.98 -5.98
16% 16%
-111%

In millions USD.

Don't miss a Thing! We will send you all news about Biomerica, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Biomerica, Inc. Stock News

Neutral
GlobeNewsWire
3 days ago
- 10-Minute At-Home PSA Test for Early Detection of Prostate Cancer - First order already shipped to Saudi Arabia - Prostate Cancer is the Second Most Common Cancer in Men Globally IRVINE, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) is pleased to announce that the Saudi Food and Drug Authority (SFDA) has approved the Company's Fortel® Prostate (PSA) Screening Test ...
Neutral
GlobeNewsWire
9 days ago
IRVINE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) today reported its financial results for the fiscal year ended May 31, 2024. The Company achieved a modest increase in net sales to $5.4 million, compared to $5.3 million in the prior year. This growth was primarily driven by strong demand for EZ Detect™ colorectal screening tests and Aware® breast self-exam produc...
Neutral
GlobeNewsWire
2 months ago
IRVINE, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, is proud to announce a major enhancement to its inFoods® IBS system, aimed at simplifying and transforming the patient experience.
More Biomerica, Inc. News

Company Profile

Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. It focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates through the following geographical segments: Europe, United States, Asia, South America, Middle East, and Other Foreign. The company was founded in September 1971 and is headquartered in Irvine, CA.

Head office United States
CEO Zackary Irani
Employees 64
Founded 1971
Website www.biomerica.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today